FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...
BioSpace12h
FDA Approves Vertex’s Journavx as First New Pain Drug in Decades
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
FDA approves Vertex's first-in-class non-opioid analgesic for acute pain
Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) ...
FiercePharma10h
Vertex scores FDA nod for long-awaited non-opioid pain reliever Journavx
Vertex has gained the FDA's approval for its non-addictive pain med Journavx, which becomes the first significant innovation ...
pharmaphorum1h
Vertex bags first FDA okay for a non-opioid pain drug
Vertex Pharma has secured FDA approval for its non-opioid pain drug suzetrigine, becoming the first new class of pain medicine in the US in more than 20 years.
Forbes1y
FDA Report Reveals 300% Increase In Cannabis Research Over The Last Decade—Key Findings
Cassandra Taylor and Schuyler Pruyn of the Center for Drug Evaluation and Research. INDs are required to conduct clinical trials in humans and transport a drug to trial sites, with applications ...
The Express Tribune6h
FDA approves non-opioid pain medication as new alternative for pain relief
The FDA approves suzetrigine, a non-opioid pain medication, offering a safer alternative to opioids for pain management, ...
Baylor College of Medicine2y
Center for Drug Discovery
most notably Texas Children’s Hospital and The University of Texas MD Anderson Cancer Center. The CDD bridges the gap between academic research and pharmaceutical discovery and provides researchers ...
Nature29d
2024 FDA approvals
The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that ...
FierceBiotech8d
New trade association sets sights on advancing multisite clinical research corporations
As multisite clinical research corporations (MCRCs) proliferate to meet the increased demand for larger clinical trials that ...